The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.

Liatsikos K, Hyder-Wright A, Davies K, El Safadi D, Farrar M, Goncalves A, Gonzalez-Dias P, Gordon SB, Howard A, Lesosky M, Liu X, Mitsi E, Myerscough C, Nyazika TK, Pollard AJ, Reiné J, Robinson RE, Solórzano C, Urban BC, Zhang Y, Lahuerta M, Theilacker C, Catusse J, Begier E, Tan Y, Jodar L, Gessner BD, Collins A, Ferreira DM, PNEUMO 2 study group

Open source

DOI: 10.1016/j.lanmic.2025.101267
Published: 2026 Mar
Container: The Lancet. Microbe
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lanmic.2025.101267,
  title = {The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.},
  author = {Liatsikos K and Hyder-Wright A and Davies K and El Safadi D and Farrar M and Goncalves A and Gonzalez-Dias P and Gordon SB and Howard A and Lesosky M and Liu X and Mitsi E and Myerscough C and Nyazika TK and Pollard AJ and Reiné J and Robinson RE and Solórzano C and Urban BC and Zhang Y and Lahuerta M and Theilacker C and Catusse J and Begier E and Tan Y and Jodar L and Gessner BD and Collins A and Ferreira DM and PNEUMO 2 study group},
  year = {2026},
  journal = {The Lancet. Microbe},
  doi = {10.1016/j.lanmic.2025.101267},
  url = {https://doi.org/10.1016/j.lanmic.2025.101267}
}

RIS

TY  - JOUR
TI  - The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.
AU  - Liatsikos K
AU  - Hyder-Wright A
AU  - Davies K
AU  - El Safadi D
AU  - Farrar M
AU  - Goncalves A
AU  - Gonzalez-Dias P
AU  - Gordon SB
AU  - Howard A
AU  - Lesosky M
AU  - Liu X
AU  - Mitsi E
AU  - Myerscough C
AU  - Nyazika TK
AU  - Pollard AJ
AU  - Reiné J
AU  - Robinson RE
AU  - Solórzano C
AU  - Urban BC
AU  - Zhang Y
AU  - Lahuerta M
AU  - Theilacker C
AU  - Catusse J
AU  - Begier E
AU  - Tan Y
AU  - Jodar L
AU  - Gessner BD
AU  - Collins A
AU  - Ferreira DM
AU  - PNEUMO 2 study group
PY  - 2026
JO  - The Lancet. Microbe
DO  - 10.1016/j.lanmic.2025.101267
UR  - https://doi.org/10.1016/j.lanmic.2025.101267
ER  -

APA

K, L., A, H., K, D., D, E. S., M, F., A, G., P, G., SB, G., A, H., M, L., X, L., E, M., C, M., TK, N., AJ, P., J, R., RE, R., C, S., BC, U., Y, Z., M, L., C, T., J, C., E, B., Y, T., L, J., BD, G., A, C., DM, F., & group, P. 2. S. (2026). The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.. The Lancet. Microbe. https://doi.org/10.1016/j.lanmic.2025.101267

Source records

pubmed · retrieved 2026-09-26T18:44:06.045Z